Movement Alert|Oscar Health Rises 5.55% in Pre-Market Trading, Wells Fargo Upgrades Rating to Equal Weight

Market Focus06-04 20:51

On June 4, Oscar Health rose 5.55% in pre-market trading, trading at $21.59/share, with trading volume of $1.97 million.

On the news front, Wells Fargo upgraded Oscar Health from Underweight to Equal Weight, significantly raising its price target from $11 to $20. According to FactSet data, the stock currently carries an average analyst rating of Hold with a mean price target of $22.18. The upgrade signals a materially improved outlook from one of the major investment banks that had previously maintained a bearish stance on the stock.

The positive catalyst helped offset negative sentiment from earlier in the week, when Oscar Health declined over 5% on June 2 following the announcement that co-founder and Chief Technology Officer Mario Schlosser stepped down from his CTO role to transition into an advisory position while remaining on the board. As a technology-driven health insurance platform, the executive change had raised concerns about strategic continuity. Wells Fargo's upgraded view appears to have provided a counterbalance, driving the pre-market rebound.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment